BOS 50 Pfizer Pill - orange & white capsule/oblong
Generic Name: bosutinib
Pill with imprint BOS 50 Pfizer is Orange & White, Capsule/Oblong and has been identified as Bosulif 50 mg. It is supplied by Pfizer Inc.
Bosulif is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BOS 50 Pfizer
Bosulif
- Generic Name
- bosutinib
- Imprint
- BOS 50 Pfizer
- Strength
- 50 mg
- Color
- Orange & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0504
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Scemblix
Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of ...
Iclusig
Iclusig (ponatinib) used to treat a type of blood cancer called chronic myeloid leukemia (CML), or ...
More about Bosulif (bosutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.